Sagimet Biosciences Inc. Quarterly Liabilities and Equity in USD from Q4 2022 to Q2 2024

Taxonomy & unit: us-gaap: USD
Description: Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.
Summary: Sagimet Biosciences Inc. quarterly Liabilities and Equity history and growth rate from Q4 2022 to Q2 2024.
Sagimet Biosciences Inc. Liabilities and Equity for the quarter ending June 30, 2024 was $189M, a 779% increase year-over-year.

Liabilities and Equity, Quarterly (USD)

Liabilities and Equity, YoY Quarterly Growth (%)

Period	Value	YoY Chg	Change %	Date	Report	Filed
Q2 2024	$189M	+$168M	+779%	Jun 30, 2024	10-Q	2024-08-14
Q1 2024	$195M			Mar 31, 2024	10-Q	2024-05-15
Q4 2023	$96.7M	+$63.7M	+193%	Dec 31, 2023	10-Q	2024-08-14
Q3 2023	$103M			Sep 30, 2023	10-Q	2023-11-13
Q2 2023	$21.5M			Jun 30, 2023	10-Q	2023-08-21
Q4 2022	$33M			Dec 31, 2022	10-K	2024-03-25

* An asterisk sign (*) next to the value indicates that the value is likely invalid.